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Abstract
Background: The recent emergence of a novel strain of influenza virus with pandemic potential underscores the
need for quality surveillance and laboratory services to contribute to the timely detection and confirmation of
public health threats. To provide a framework for strengthening disease surveillance and response capacities in
African countries, the World Health Organization Regional Headquarters for Africa (AFRO) developed Integrated
Disease Surveillance and Response (IDSR) aimed at improving national surveillance and laboratory systems. IDSR
emphasizes the linkage of information provided by public health laboratories to the selection of relevant,
appropriate and effective public health responses to disease outbreaks.
Methods: We reviewed the development of Rwanda’s National Reference Laboratory (NRL) to understand essential
structures involved in creating a national public health laboratory network. We reviewed documents describing the
NRL’s organization and record of test results, conducted site visits, and interviewed health staff in the Ministry of
Health and in partner agencies. Findings were developed by organizing thematic categories and grouping
examples within them. We purposefully sought to identify success factors as well as challenges inherent in
developing a national public health laboratory system.
Results: Among the identified success factors were: a structured governing framework for public health
surveillance; political commitment to promote leadership for stronger laboratory capacities in Rwanda; defined
roles and responsibilities for each level; coordinated approaches between technical and funding partners;
collaboration with external laboratories; and use of performance results in advocacy with national stakeholders.
Major challenges involved general infrastructure, human resources, and budgetary constraints.
Conclusions: Rwanda’s experience with collaborative partnerships contributed to creation of a functional public
health laboratory network.
Background
Communicable diseases remain the leading cause of ill-
ness, death and disability in African countries [1,2].
Even though well-known, efficacious responses are
available for the control and prevention of these dis-
eases, the capacity for timely detection, confirmation
and response actions needs reliable public health sys-
tems. To address the demand from countries for
improved surveillance systems that provide relevant
and accurate epidemiologic and laboratory information,
the Member States of the World Health Organization
(WHO) Regional Headquarters for Africa (AFRO)
adopted a strategy in 1998 called Integrated Disease
Surveillance and Response (IDSR) [2]. A major goal of
IDSR is to strengthen district-level surveillance capaci-
ties for detecting, confirming and responding to prior-
ity diseases that afflict African communities. In the
IDSR implementation framework, epidemiologic
surveillance is linked with laboratory support in order
to produce relevant information for taking public
health action [3].
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the role of public health laboratories in national surveil-
lance systems through a resolution in 2008 which called
for the organization of national public health laboratory
networks that would link national laboratories with sub-
regional, regional and international laboratories [4,5].
T h u sap u b l i ch e a l t hl a b o r a t o r yn e t w o r ki sac o l l e c t i o n
of laboratories that use standard operating procedures,
carry out quality assessments, and report information
for public health action in a systematic manner [4].
With the adoption of the revised International Health
Regulations (2005) and the commitment of countries to
achieve disease reduction targets set by the Millennium
Development Goals (MDGs), countries are facing
increased demands to rapidly improve their public
health systems. The IHR (2005) are especially clear in
calling for strengthening core capacities for detecting
and confirming public health threats, especially those
with potential to extend beyond national borders [6].
Thus progress in countries with limited resources
depends on identifying opportunities for creating and
streamlining resources to achieve functional national
laboratory networks that meet national priorities and
support global disease program objectives [7].
Disease-specific guidelines provide robust recommen-
dations to create laboratory networks, but may not
always include guidance on how to organize, mobilize
and integrate the essential resources, procedures, and
policies for creating and maintaining a laboratory net-
work within a national public health surveillance system
[8,9]. Thus we wanted to examine Rwanda’s eight-year
(from 2000 to 2007) experience with IDSR to see how
the country developed a public health laboratory net-
work through coordination of multiple resources and
technical support in order to meet national priorities
and partner interests.
In 2005, the Rwandan Ministry of Health commis-
sioned an independent assessment of the national
laboratory network to determine its status in relation to
the national reference laboratory and for disease preven-
tion programs [10]. Subsequently, in 2006, a team from
WHO/AFRO, the United States Centers for Disease
Control and Prevention (CDC) and the Rwanda
National Reference Laboratory (NRL) in the Ministry of
Health met to review Rwanda’s public health laboratory
network. The intention was to use the review findings
to inform guidance for other countries that would make
explicit practical factors to consider when implementing
a public health laboratory network.
Methods
A multi-agency team reviewed published and unpub-
lished reports related to the implementation of Rwanda’s
laboratory activities, conducted site visits to observe how
the laboratories functioned, and interviewed staff at the
Ministry of Health and partner agencies. The National
Reference Laboratory (NRL) coordinated the site visits
to seven district hospitals and two health centers. These
sites were selected as a convenience sample because
each health center and district hospital in Rwanda offers
the same standardized group of laboratory tests as speci-
fied by government policy. Interviews and follow-up dis-
cussions were conducted with laboratory personnel in
charge of the district hospital and health center labora-
tories. Interviewees included district supervisors and
representatives of disease-specific programs for tubercu-
losis (TB), malaria, and HIV/AIDS. We also met with
personnel at the Ministry of Health’s Epidemiology and
Health Prevention unit, and with staff responsible for
the Health Management Information System. Experi-
ences with external support to laboratory services were
gathered through interviews with locally-based partners
who worked closely with the Ministry of Health and the
NRL including WHO, CDC, Columbia University and
the United States Agency for International Development
(USAID).
To guide our review, we adapted an assessment proto-
col developed by WHO, CDC and USAID for use in
IDSR programs in African countries [11]. Topics assessed
included clarification of the disease surveillance goals and
activities for the country, the role of the laboratory in
surveillance activities, the coordination and structure of
the laboratory network, and the collaboration of partners
and resources for creating quality laboratory services for
disease outbreak investigations and response.
Results
Surveillance goals and activities in the country
Rwanda’s implementation of IDSR began in 2000 with a
national assessment of the country’s communicable dis-
ease surveillance program. The results of the assessment
were used to develop a strategic plan for improving the
country’s surveillance, laboratory and response capaci-
ties. The WHO/AFRO IDSR technical guidelines were
adapted to ensure that Rwandan disease priorities would
be emphasized in the streamlined system. Training of
health workers on IDSR approaches began in 2001.
Additional training in laboratory and data management
was provided for relevant staff through national and
regional training workshops. The initial IDSR strategy in
Rwanda targeted 19 priority diseases and syndromes
(Table 1) recommended by WHO-AFRO because they
are among the leading causes of illness, death and dis-
ability in African countries and are relevant to Rwanda
based on epidemiologic criteria [3]. Implementation of
the full IDSR program within the Ministry of Health is
still under development; the focus of this review is on
the laboratory component.
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The Rwanda health service consists of a referral system
encompassing three levels of health care: referral, dis-
trict and health center levels. In the whole country,
there are four referral hospitals, 34 district hospitals,
and 385 health centers. At the central level, the NRL’s
mandate is to provide referral laboratory services to all
health-care providers in the country, to prepare and dis-
tribute laboratory specimen transport media, to develop
policies and to enforce standards for all laboratories in
the country. The NRL also oversees the licensing, certifi-
cation and accreditation of private and public health
laboratories.
The NRL has autonomous status thus highlighting its
role in promoting stronger laboratory capacities and lea-
dership in disease control activities. Specific responsibil-
ities of the NRL involve improved diagnostic capacities
for HIV, tuberculosis, and malaria. The NRL also has
capacity to identify and isolate bacterial causes of out-
breaks. Additionally, the NRL’s capacity to diagnose
other diseases was expanded with support from USAID
and CDC to diagnose influenza subtypes A and H5N1
as part of the country’s epidemic preparedness and con-
trol activities.
Within the NRL, the laboratory personnel participate
in investigations of suspected disease outbreaks in sev-
eral ways. They ensure that specimen transport media is
available. They also process and test specimens and then
ship specimens to regional or international laboratories
for further characterization as required by disease-speci-
fic guidelines. Other activities include training, supervi-
sion, and quality assessments for laboratories at all
levels of the national health system.
A tt h et i m eo ft h i sr e v i e w ,t h eG o v e r n m e n to fR w a n d a
was involved in decentralization of administrative func-
tions that also impacted the health sector. Decentraliza-
tion was seen as an opportunity for expanding laboratory
capacity, improving data management and maximizing
the use of surveillance information at all levels of the
health care system in line with the IDSR strategy. In the
Department of Epidemiology and Public Hygiene
(DEHP), decentralization focused on improving coordi-
nation of disease surveillance with the alert and response
system at the district level. Among the changes fostered
by decentralization, a Geographic Information System
(GIS) was set up, and bacteriology laboratories were
established at five district hospital laboratories.
Coordination and function of the laboratory network
The laboratory network in Rwanda is aligned with the
overall three-tiered organization (central, district and
peripheral levels) of the national health system. The net-
work connects the central level’s four reference hospital
laboratories and the National Reference Laboratory with
34 district hospital laboratories at the intermediate level
and 385 health center laboratories at the peripheral
level.
Each level has a defined role supported by standard
operating procedures (SOPs) that specify the safe collec-
tion, handling, storing, shipping and processing of
laboratory specimens. Supervision and feedback are car-
ried out using a level-specific checklist. The SOPs spe-
cify communication channels and procedures linking
each level for the referral of laboratory specimens,
reporting of data, supervision and quality assurance
activities. For example, the district hospital laboratories
submit weekly reports of selected priority diseases. The
district level performs commonly requested laboratory
tests such as hematology, clinical chemistry, urine analy-
sis and parasitology. At the health center level, labora-
tories perform microscopy for detecting malaria,
tuberculosis and other bacterial and parasitic agents.
Almost all health center laboratories have the capacity
to do human immunodeficiency virus (HIV) rapid test-
ing. For some disease programs such as malaria, the net-
work extends to the community level where volunteers
are trained in detection and treatment of malaria includ-
ing home-based management of malaria. The commu-
nity volunteers contribute to surveillance activities by
referring patients to health centers for laboratory
services.
Services at the National Reference Laboratory
The laboratory capacity for the isolation and identifica-
tion of bacterial pathogens has been established at the
NRL. Specimens for bacteria such as Vibrio cholerae,
Salmonella typhi, Shigella species, Neisseria meningitidis
and Haemophilus influenzae are collected from the per-
ipheral levels and transported to the NRL where they
are analyzed. The results are fed back to the districts
and also shared with WHO/AFRO on a monthly basis.
Table 1 Priority diseases and syndromes for Integrated
Disease Surveillance and Response in Rwanda
Epidemic prone
diseases and
syndromes
Diseases targeted for
eradication and
elimination
Other diseases of public
health importance
Cholera
Bacillary dysentery
Plague
Yellow fever
Meningococcal
meningitis
Vial hemorrhagic
fever
Severe acute
respiratory
syndrome (SARS)
Avian influenza
(AI)
Poliomyelitis
Dracunculiasis
Neonatal tetanus
Leprosy
Diarrhea with dehydration
in children less than 5
years of age
Pneumonia in children
less than 5 years of age
HIV/AIDS
Malaria
Trypanosomiasis
Tuberculosis
Onchocerciasis
Kebede et al. Health Research Policy and Systems 2011, 9:27
http://www.health-policy-systems.com/content/9/1/27
Page 3 of 8Laboratory capacity for HIV is one of the most devel-
oped services in Rwanda, with major financial and tech-
nical support from the United States Government’s
President’s Emergency Plan for AIDS Relief (PEPFAR)
through CDC, other US Government organizations, the
Mailman School of Public Health at Columbia Univer-
sity, the Global Fund, UNICEF and others. The NRL,
located in Kigali, is equipped to perform the necessary
biological tests required for the evaluation, treatment,
and follow-up of HIV/AIDS patients including HIV
rapid tests, viral load, and PCR. The NRL plays a leading
role in organizing and setting up new HIV laboratory
services (such as monitoring HIV treatment resistance),
training, supervision, data management, and operational
research.
The capacities for polymerase reaction (PCR), CD4
and viral load measurements have been available at the
NRL since 2004. These capacities were expanded
through collaboration with partners due to decentraliza-
tion by providing services for fluorescence-activated cell
sorting including FACS Count™ and FACS Calibur™
instruments. For example, two FACS Calibur™ instru-
ments are at the NRL, 23 are in district hospitals and
one is at a private research clinic in Kigali. At the end
of 2005, the NRL performed nearly 70% of all CD4
counts conducted in the country. By 2007-2008, this fig-
ure from the NRL dropped to 36% due to increased
capacity to conduct CD4 counts in 23 district hospitals.
Plans are under way to upgrade the FACS™ Count
instrument for assessing lymphocyte percentages for
infants.
Decentralization of services was also implicated in
expansion of access to antiretroviral treatment (ART) at
the national level. Following the Rwanda National Pae-
diatric Conference in 2004, there was recognition that
early infant diagnosis of mother-to-child transmission
(PMTCT) and ART sites should be expanded at all
levels of the health system. In July 2005, with support
from CDC, three paediatric diagnostic sites were estab-
lished for early infant diagnosis using either dried blood
spots (DBS) or whole blood methods. By April 2008, the
number of rapid diagnostic sites had expanded to 126.
Training of laboratory personnel
The strengthening of laboratory capacity including advo-
cacy, provision of laboratory equipment, training and
research was achieved through partner resources for
specific tests and procedures. The training topics
included advanced techniques for tuberculosis diagnosis
(for example, testing for multi-drug resistance), HIV/
AIDS testing (HIV serology, CD4 counts, and PCR for
infant diagnosis of HIV), and techniques for hematology,
biochemistry, and parasitology, including blood smears
to detect malaria and intestinal helminths. Training
topics also included good laboratory practices, bio-
safety, biological sample collection, and the safe trans-
port, handling and storage of specimens. In 2005, the
NRL trained 467 biotechnologists on laboratory detec-
tion of malaria, TB, HIV rapid testing, standard labora-
tory practices and biosafety. In 2007, 969 laboratory
personnel completed an integrated laboratory training in
malaria, TB, and HIV (471 participants), biochemistry
and haematology (61 participants) as well as training in
how to perform CD4 counts (34 participants), conduct
testing with dried blood spots (180 participants) and
carry out HIV-specific testing at new VCT sites (223
participants).
Supervision of laboratory activities within the national
network
The national reference laboratory coordinates and car-
ries out supervision for laboratory activities in referral
hospitals, district hospitals, health centres and private
clinics. The supervisory activities, which take place each
trimester, are integrated across disease and subject areas
and include: TB, malaria, HIV, biochemistry, and hae-
matology. Supervision of bacteriology activities is carried
out separately at referral and district hospitals only.
During the supervisory visits, a check list is used to
assess performance in technical activities, the extent of
compliance with SOPs, the quality and reporting of
results, record keeping, internal quality controls, instru-
ment performance (especially microscopes and spectro-
photometers), availability and quality of reagents, and
management of consumables. The extent of reliably
available utilities (such as water and electricity), labora-
tory space and standard biosecurity capacities are also
assessed. There are 420 facilities that receive at least one
visit per year. Some may receive two or three visits dur-
ing the year depending on the supervisory results. The
number of actual supervisory visits to laboratory sites is
maintained at a high level, e.g., 517 in 2005, 862 in
2006, and 689 in 2007. The supervisory visit data is ana-
lyzed and feedback is given to the respective health
facilities. When results are not satisfactory, the NRL
intervenes for corrective actions, in the form of retrain-
ing or amelioration of other causes of poor performance.
Plans are underway to decentralize quality control and
supervisory activities. In the new plan, the district hospi-
tal laboratories will take charge of the health centers
while the NRL will supervise the referral hospitals, the
district hospital and private laboratories.
Collaboration with external laboratories
D i s e a s es p e c i f i cp r o g r a m si nR w a n d aa r em a n a g e db y
the Government of Rwanda in collaboration with part-
ners such as WHO, the Global Fund and PEPFAR.
Mapping of health facilities ensures that each partner
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aligned in support of national goals and objectives for
control and prevention programs targeting HIV/AIDS,
TB, malaria, epidemic disease surveillance and opportu-
nistic infections. In this way, partner resources comple-
ment each other to fill the gaps in terms of sharing
equipment, reagents, consumables, human resources
and technical support. Merging of the HIV/AIDS, TB
and malaria programs into one institution called the
Treatment and Research AIDS Center (TRAC Plus)
allows for clinical planning and laboratory activities in
addition to collaboration at high levels. This coordina-
tion aims to avoid overlapping or duplication of activ-
ities in any area.
We observed examples of collaboration between
national disease programs and the national and external
reference laboratory systems such as those for polio,
measles, and multi-disease resistant TB activities. For
example, a key component in many WHO disease eradi-
cation or elimination programs (such as the polio eradi-
cation activity within the Expanded Programme on
Immunization or EPI), is the collaboration between
national disease programs and the national and external
reference laboratory systems. In the case of polio eradi-
cation in Rwanda, the transport of stool specimens from
patients with acute flaccid paralysis (AFP) originates at
peripheral levels through district hospitals and then to
the NRL or to the WHO-EPI program in Rwanda. The
NRL or WHO-EPI program in turn ships these speci-
mens to the Ugandan Virus Research Institute in
Entebbe, Uganda (UVRI) for confirmation and charac-
terization of the organism. The results are reported back
to Rwanda’sN R La n dE P Io f f i c e sa n dt h e ns h a r e dw i t h
the WHO. The results are communicated to the district
health team and health facilities that use the results to
inform timely and relevant public health response
actions.
For monitoring of the measles program, serum speci-
mens from patients with suspected measles are collected
and transported from the health facilities to the NRL.
The samples are analyzed for viral antibodies by ELISA.
The results are given to EPI for their use in determining
a timely response. The results are shared with WHO-
AFRO on a monthly basis. Serum specimens also are
sent to UVRI on a quarterly basis for external quality
control. In addition, the NRL receives quality control
panels every quarter from UVRI.
Monitoring for multi-drug resistant TB is done by the
NRL, and some specimens are subsequently referred to
the external laboratory at the Institute of Tropical Medi-
cine (IMTA) in Antwerp, Belgium for quality control
(QC) testing. The QC panel samples for epidemic bac-
teria, malaria and TB microscopy, CD4 counts, HIV
ELISA and Western Blot are received from the National
Institute of Public Health (NIPH) in South Africa every
quarter. The QC panels for assessing PCR capacity are
received from CDC in Atlanta, USA.
Laboratory results from the network
Table 2 illustrates examples of data produced through
the laboratory network in support of the communicable
disease surveillance system. Specimens reflected in the
table are referred specimens or specimens collected by
the national reference laboratory for confirmation of
suspected cases during outbreak investigation or surveil-
lance. Once specimens are confirmed according to
Table 2 Bacteriologic specimens and strains isolated by the National Reference Laboratory 2005 to 2007
2005 2006 2007
Suspected
outbreak
Specimen
type
Number of
specimens
received
Number of
confirmed
isolates
Number of
specimens
received
Number of
confirmed
isolates
Number of
specimens
received
Number of confirmed
isolates
Cholera Stool 46 3 V. cholerae 01
Ogawa
8 V. cholerae 01
Inaba
17 2 V. Cholerae 01
Ogawa
110 8 V. cholerae 01 Ogawa
1 V. cholerae 01 Hikojima
Dysentery Stool 11 None None None 110 (same
specimens as for
cholera)
4 E. coli 0157: H7 1 Shigella
flexneri 1 Shigella sonnei
Measles Blood 188 0 measles
28 rubella
187 42 measles
23 rubella
132 12 measles
18 rubella
Typhoid
fever
Blood 42 8 Salmonella
typhi
1 Salmonella.
paratyphi B
44 3 Salmonella
typhi
1 Staphylococcus
aureus
132 3 Salmonella typhi
1 Staphylococcus aureus
Meningitis Cerebro-
spinal
fluid
20 2 N. meningitidis
5 Streptococcus
pneumoniae
21 6 Streptococcus
pneumoniae
22 6 S. pneumoniae
1 S. agalactiae
1 C. neoformans
1 C. albudis
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specimens for laboratory investigations. Specimens con-
tinue to be processed to inform clinical management.
The NRL conducts quality control (QC) and quality
assurance (QA) activities for all levels of the network
laboratories at regular intervals. The NRL also partici-
pates in the WHO-AFRO External Quality Assessment
(EQA) scheme for enteric and meningitis pathogens, TB
and malaria. External quality assurance for HIV, measles
and selected bacterial diseases is carried out through
designated international partner or disease-specific colla-
borating laboratories. As an example, in 2003, 100%
concordance was reported for the unlinked, anonymous
HIV testing in a total of 288 samples sent to CDC-
Atlanta.
Health centres and district health facilities regularly
send 10% of randomly selected HIV positive and 5%
HIV negative specimens to the NRL for quality control
assessment. The number of voluntary counselling and
testing sites (VCT) participating in this QC program has
increased yearly: there were 44 in 2003, 129 in 2004,
229 in 2005, 256 in 2006 and 313 in 2007. According to
the 2007 annual report from the Rwanda Treatment and
Research AIDS Center (TRAC), the number of sites for
paediatric treatment (PMTCT) increased markedly
between 2003 and 2007; there were 53 in 2003, 120 in
2004, 209 in 2005, 234 in 2006 and 285 in 2007. The
QC results showed good performance with discordance
rates decreasing over time: 3%, in 2003, 2.6% in 2004,
2% in 2005, 1% in 2007, and 0.8% in 2008. The NRL
also collects 15 TB-slides per site per quarter for QC
from health facilities (Center for Diagnosis and Treat-
ment or CDT sites) in the country. The number of sites
participating in QC and smear-positivity results from
2003 to 2007 is shown in Table 3.
T oe n s u r et h eq u a l i t yo fm e a sles laboratory testing,
each trimester the NRL sends 10% of the total measles
and rubella samples received at the NRL to the Uganda
Virus Research Institute (UVRI). The NRL also receives
20 panel specimens each year from the UVRI. The panels
are tested and results are subsequently shared with
UVRI. In 2004, the result showed good concordance and
the NRL was subsequently accredited for measles labora-
tory confirmation by WHO/AFRO. In 2005, the Rwandan
NRL obtained 95% concordance for measles and rubella
testing.
Challenges to the network
Documented reports and participant responses sug-
gested that achieving a public health laboratory network
is not without considerable challenges in major areas.
For example, written reports and interviewee responses
noted the following obstacles: a delay implementing an
integrated strategy for improving an integrated public
health surveillance and response strategy, insufficient
number of skilled human resources, weaknesses in the
general infrastructure, and shortages of vehicles, equip-
ment, supplies, and reagents.
One of the major limitations cited by participants has
been the delayed implementation of IDSR in Rwanda.
Without a functional IDSR strategy in place, health staff
reported that the role of laboratory is not well under-
stood in its context of a broader public health surveil-
l a n c en e t w o r k .W h i l et h e r ei sas t r a t e g i cp l a nw i t h
defined goals for IDSR in place, implementation of the
plan has yet to be fully implemented. At the time of this
review, the surveillance and reporting system was using
multiple forms from a variety of implementing partners
resulting in a duplication of effort and resources.
The shortage of skilled human resources at all levels is
due to high attrition and turnover of trained personnel.
Decentralization has resulted in a gap in human
resources for specialized testing at the national level and
routine functions at the district and health facility levels.
The long distances between some health centers and the
national level - in addition to difficult driving conditions
in some areas - contributes to a situation where speci-
mens arrive at the NRL in inadequate condition (for
example, hemolyzed samples for CD4 and measles IgM
testing). Computer and internet access for transmitting
data is affected by the erratic supply of electricity.
Finally, participants described working within the con-
text of ongoing shortages of vehicles, fuel, laboratory
safety equipment, laboratory supplies and reagents.
Table 3 Quality control for TB slide examination from TB Diagnosis and Treatment Center (CDT) sites*
Year Number of CDT sites
participating in QC
Number of TB
slides (specimens)
Percent (%) TB-
smear positive
Percent (%) with false
positive result
Percent (%) with false
negative result
Overall
performance
2003 60 No records available
2004 134 No records available
2005 147 3622 13.7% 6.4% 2.6% Not rated
2006 173 7370 11.3% 4.1% 1% Good
2007 183 9057 6.6% 2.7% 0.5% Good
*The NRL was initiated in 2003 and organization of the network began in 2004. The lab network was able to begin reporting number of specimens by 2005. We
attribute the gradual decrease from 13.7% to 6.5% to comprehensive training of laboratory technicians and to the national TB program in its goals for reducing
spread of TB.
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The government of Rwanda, through collaboration with
its partners, has begun to strengthen the organizational
capacity of the public health laboratory network for
identification and confirmation of priority diseases. The
laboratory network has a hierarchal structure with the
central referral laboratories as lead authorities and the
health centre-based laboratories at the periphery. Other
referral hospitals laboratories also link to the National
Reference Laboratory. There is a defined role for each
level with level-specific standard operating procedures.
The NRL is the focal point for national public health
laboratory leadership and coordination of partners to
establish and expand the laboratory network. Reporting
on specimens processed from the district and hospital
laboratories is integrated and submitted along with the
weekly disease reports for selected priority diseases.
Supervision and feedback is done using a check list as
applicable to the different levels.
The benefits of an organized laboratory network are
evident in the increases in capacity and performance as
illustrated in Tables 2 and 3. Table 2 illustrates an
increase over time in the number of specimens received
and isolates confirmed by the NRL between 2005 and
2007, and Table 3 highlights a 3-fold increase during
the same time period in the number of health facility
laboratories participating in quality control for TB
microscopy.
The laboratory network in Rwanda is contributing to
the successful strengthening of the disease surveillance
and response system by ensuring involvement of the
public health laboratory network in the planning for
IDSR, laboratory participation in outbreak investigations,
engagement in feedback communications, integration of
laboratory indicators to monitor progress, and develop-
ing mechanisms for coordination of epidemic prepared-
ness and response at all levels. The coordination and
leadership role of the NRL and the commitment of mul-
tiple partners under its leadership provide unique
opportunities for strengthening the laboratory network-
ing in Rwanda.
Because a major focus in IDSR implementation is to
strengthen the district level, the ongoing decentraliza-
tion process provides a good opportunity for expanding
IDSR implementation in all districts. Recently, a Field
Epidemiology and Laboratory Training Program was
established which will eventually result in considerable
capacity building, especially if the applied training pro-
gram is accompanied by a well- structured human
resources plan for a career path through and retention
of competent laboratory staff at all levels of the network.
The strengthening of the collaboration between the
NRL and the Treatment and AIDS Research Center
(TRAC Plus) through the Center for Communicable
Disease Control in Rwanda will lead to improved coor-
dination. As a first step, an integrated informatics sys-
tem and a national integrated surveillance system are
being developed, which will facilitate not only communi-
cation of data but also the sharing of results. A recom-
mendation of the study team to the NRL was to
consider implementation of international standards such
as OECD’s Global Laboratory Practices (GLP) [12] and
to seek international accreditation.
Conclusions
Recommendations for creating a functional public health
laboratory network usually highlight the need for: (1)
defined communication channels between the various
levels of the health system, (2) explicit linkages with rele-
vant Ministry of Health divisions, (3) a structure for coor-
dination of laboratory activities, and (4) collaboration
with funding and technical partners [5,7,8]. These ele-
ments of a laboratory network were evident in our
review. For example, Rwanda’s laboratory network bene-
fits not only from government ownership and partner
commitment but also from the defined structures and
communication linkages between levels of the health sys-
tem and with partners. Responsibility for coordination of
laboratory activities through the NRL and TRAC Plus
provides a structure for avoiding duplication of resources.
The example of the collaboration between the govern-
ment of Rwanda and its technical and funding partners
in creating a functional laboratory network that provides
results is one that can be emulated by other countries.
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